Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran

There is still a lack of effective biomarkers for the prediction of the risk of bleeding events among patients with nonvalvular atrial fibrillation (NVAF) taking dabigatran. This study aimed to investigate the association between change in total bilirubin (CTBIL) and risk of bleeding among patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Yurong, Hu, Lihua, Zhou, Wei, Li, Minghui, Wang, Tao, Huang, Xiao, Bao, Huihui, Cheng, Xiaoshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288843/
https://www.ncbi.nlm.nih.gov/pubmed/32343610
http://dx.doi.org/10.1177/1076029620910808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288843/
https://www.ncbi.nlm.nih.gov/pubmed/32343610
http://dx.doi.org/10.1177/1076029620910808

Ejemplares similares